Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.93)
# 3,533
Out of 5,058 analysts
314
Total ratings
51.6%
Success rate
0.2%
Average return
Main Sectors:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PGNY Progyny | Rated: Buy | $37 | $26.86 | +37.75% | 2 | Oct 16, 2026 | |
| OMCL Omnicell | Rated: Buy | $50 | $35.39 | +41.28% | 56 | Oct 14, 2026 | |
| OMDA Omada Health | Rated: Hold | $22 | $17.63 | +24.79% | 6 | Oct 13, 2026 | |
| VEEV Veeva Systems | Reiterated: Buy | $330 | $310.36 | +6.33% | 46 | Sep 30, 2026 | |
| HQY HealthEquity | Rated: Buy | $125 | $92.09 | +35.74% | 60 | Sep 29, 2026 | |
| PHR Phreesia | Rated: Hold | $9 → $10 | $10.94 | -8.59% | 7 | Sep 3, 2026 | |
| WAY Waystar Holding | Reiterated: Buy | $33 | $27.36 | +20.61% | 4 | Aug 19, 2026 | |
| HCAT Health Catalyst | Rated: Hold | $1.75 → $1.5 | $1.73 | -13.04% | 27 | Aug 13, 2026 | |
| CTEV Claritev | Reiterated: Hold | $22 → $30 | $22.12 | +35.62% | 4 | Aug 12, 2026 | |
| DOCS Doximity | Downgraded: Sell | $18 | $30.97 | -41.88% | 34 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $11.68 | +36.99% | 18 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $6 | $5.67 | +5.82% | 9 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $90 | $99.16 | -9.24% | 5 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 | $3.36 | +4.17% | 35 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $17.50 | n/a | 1 | Oct 6, 2015 |
Progyny
Oct 16, 2026
Rated: Buy
Price Target: $37
Current: $26.86
Upside: +37.75%
Omnicell
Oct 14, 2026
Rated: Buy
Price Target: $50
Current: $35.39
Upside: +41.28%
Omada Health
Oct 13, 2026
Rated: Hold
Price Target: $22
Current: $17.63
Upside: +24.79%
Veeva Systems
Sep 30, 2026
Reiterated: Buy
Price Target: $330
Current: $310.36
Upside: +6.33%
HealthEquity
Sep 29, 2026
Rated: Buy
Price Target: $125
Current: $92.09
Upside: +35.74%
Phreesia
Sep 3, 2026
Rated: Hold
Price Target: $9 → $10
Current: $10.94
Upside: -8.59%
Waystar Holding
Aug 19, 2026
Reiterated: Buy
Price Target: $33
Current: $27.36
Upside: +20.61%
Health Catalyst
Aug 13, 2026
Rated: Hold
Price Target: $1.75 → $1.5
Current: $1.73
Upside: -13.04%
Claritev
Aug 12, 2026
Reiterated: Hold
Price Target: $22 → $30
Current: $22.12
Upside: +35.62%
Doximity
Aug 10, 2026
Downgraded: Sell
Price Target: $18
Current: $30.97
Upside: -41.88%
Aug 5, 2026
Reiterated: Buy
Price Target: $16
Current: $11.68
Upside: +36.99%
Jul 30, 2026
Reiterated: Hold
Price Target: $6
Current: $5.67
Upside: +5.82%
Jun 24, 2026
Rated: Buy
Price Target: $80 → $90
Current: $99.16
Upside: -9.24%
Jun 2, 2026
Reiterated: Buy
Price Target: $3.5
Current: $3.36
Upside: +4.17%
Oct 6, 2015
Initiated Coverage: Buy
Price Target: $34
Current: $17.50
Upside: n/a